These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1894946)

  • 1. Lipoprotein 90K in human immunodeficiency virus-infected patients: a further serologic marker of progression.
    Iacobelli S; Natoli C; D'Egidio M; Tamburrini E; Antinori A; Ortona L
    J Infect Dis; 1991 Oct; 164(4):819. PubMed ID: 1894946
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between the tumour-associated antigen 90K and cytokines in the circulation of persons infected with human immunodeficiency virus.
    Senaldi G; Peakman M; Natoli C; Hussain MJ; Gallati H; McManus T; Vergani D; Iacobelli S
    J Infect; 1994 Jan; 28(1):31-9. PubMed ID: 8163831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection.
    Natoli C; Dianzani F; Mazzotta F; Balocchini E; Pierotti P; Antonelli G; Iacobelli S
    J Acquir Immune Defic Syndr (1988); 1993 Apr; 6(4):370-5. PubMed ID: 8095982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men.
    Briggs NC; Natoli C; Tinari N; D'Egidio M; Goedert JJ; Iacobelli S
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):811-6. PubMed ID: 7504933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patients.
    Longo G; Natoli C; Rafanelli D; Tinari N; Morfini M; Rossi-Ferrini P; D'Ostilio N; Iacobelli S
    Br J Haematol; 1993 Sep; 85(1):207-9. PubMed ID: 8251396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusually high level of a tumor-associated antigen in the serum of human immunodeficiency virus-seropositive individuals.
    Natoli C; Iacobelli S; Ghinelli F
    J Infect Dis; 1991 Sep; 164(3):616-7. PubMed ID: 1869854
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic value of a novel interferon-inducible 90K tumor antigen.
    D'Ostilio N; Natoli C; Grassadonia A; Rossi N; Di Stefano P; Amatetti C; Tinari N; Iacobelli S
    Ann N Y Acad Sci; 1996 Apr; 784():288-93. PubMed ID: 8651577
    [No Abstract]   [Full Text] [Related]  

  • 8. The secreted tumor-associated antigen 90K is a potent immune stimulator.
    Ullrich A; Sures I; D'Egidio M; Jallal B; Powell TJ; Herbst R; Dreps A; Azam M; Rubinstein M; Natoli C
    J Biol Chem; 1994 Jul; 269(28):18401-7. PubMed ID: 8034587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific.
    Lodermeyer V; Ssebyatika G; Passos V; Ponnurangam A; Malassa A; Ewald E; Stürzel CM; Kirchhoff F; Rotger M; Falk CS; Telenti A; Krey T; Goffinet C
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal Cancer.
    Wu KL; Chen HH; Pen CT; Yeh WL; Huang EY; Hsiao CC; Yang KD
    Biomed Res Int; 2015; 2015():306964. PubMed ID: 26448934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancer.
    Zeimet AG; Natoli C; Herold M; Fuchs D; Windbichler G; Daxenbichler G; Iacobelli S; Dapunt O; Marth C
    Int J Cancer; 1996 Sep; 68(1):34-8. PubMed ID: 8895537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
    Iacovazzi PA; Trisolini A; Barletta D; Elba S; Manghisi OG; Correale M
    Clin Chem Lab Med; 2001 Oct; 39(10):961-5. PubMed ID: 11758611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesions.
    Cesinaro AM; Natoli C; Grassadonia A; Tinari N; Iacobelli S; Trentini GP
    J Invest Dermatol; 2002 Jul; 119(1):187-90. PubMed ID: 12164944
    [No Abstract]   [Full Text] [Related]  

  • 14. Elevated serum levels of a 90,000 daltons tumor-associated antigen in cancer and in infection by human immunodeficiency virus (HIV).
    Natoli C; Ortona L; Tamburrini E; Tinari N; Di Stefano P; D'Egidio M; Ghinelli F; Sighinolfi L; D'Ostilio N; Piazza M
    Anticancer Res; 1994; 14(3B):1457-60. PubMed ID: 8067721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic juice 90K and serum CA 19-9 combined determination can discriminate between pancreatic cancer and chronic pancreatitis.
    Gentiloni N; Caradonna P; Costamagna G; D'Ostilio N; Perri V; Mutignani M; Febbraro S; Tinari N; Iacobelli S; Natoli C
    Am J Gastroenterol; 1995 Jul; 90(7):1069-72. PubMed ID: 7611198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral markers of active Epstein-Barr virus infection associate with anti-extractable nuclear antigen autoantibodies and plasma galectin-3 binding protein in systemic lupus erythematosus.
    Rasmussen NS; Nielsen CT; Houen G; Jacobsen S
    Lupus; 2016 Dec; 25(14):1567-1576. PubMed ID: 27084029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 90K (Mac-2 BP) predicts CD4 decline in human immunodeficiency virus-infected patients with CD4 counts above 200 x 10(6) cells/L.
    Tinari N; Natoli C; D'Ostilio N; Ghinelli F; Sighinolfi L; Ortona L; Tamburrini E; Piazza M; Chirianni A; Guerra L; Di Gregorio P; Iacobelli S
    Arch Pathol Lab Med; 1998 Feb; 122(2):178-81. PubMed ID: 9499363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer.
    Scambia G; Panici PB; Baiocchi G; Perrone L; Iacobelli S; Mancuso S
    Anticancer Res; 1988; 8(4):761-4. PubMed ID: 3178164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90K.
    Zeimet AG; Stadlmann S; Natoli C; Widschwendter M; Hermann M; Abendstein B; Daxenbichler G; Offner FA; Iacobelli S; Marth C
    Anticancer Res; 2000; 20(6B):4507-11. PubMed ID: 11205296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum protein 90K/Mac-2BP is an independent predictor of disease severity during hepatitis C virus infection.
    Kittl EM; Hofmann J; Hartmann G; Sebesta C; Beer F; Bauer K; Huber KR
    Clin Chem Lab Med; 2000 Mar; 38(3):205-8. PubMed ID: 10905755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.